Incidence and outcomes of perioperative myocardial infarction/injury diagnosed by high-sensitivity cardiac troponin I

[1]  L. Steiner,et al.  Etiology of Peri-Operative Myocardial Infarction/Injury After Noncardiac Surgery and Associated Outcome. , 2020, Journal of the American College of Cardiology.

[2]  Kyunga Kim,et al.  Comparison of acute and chronic myocardial injury in noncardiac surgical patients , 2020, PloS one.

[3]  P. Devereaux,et al.  Myocardial injury after non-cardiac surgery: diagnosis and management. , 2019, European heart journal.

[4]  S. Blankenberg,et al.  Gender-Specific Reference Values for High-Sensitivity Cardiac Troponin T and I in Well-Phenotyped Healthy Individuals and Validity of High-Sensitivity Assay Designation. , 2019, Clinical biochemistry.

[5]  R. Twerenbold,et al.  Biomarkers in cardiovascular medicine: towards precision medicine. , 2019, Swiss medical weekly.

[6]  F. Apple,et al.  Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. , 2019, JAMA cardiology.

[7]  M. Lalu,et al.  Postoperative shared-care for patients undergoing non-cardiac surgery: a systematic review and meta-analysis , 2019, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[8]  Ò. Miró,et al.  High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. , 2019, Clinical chemistry.

[9]  Jeroen J. Bax,et al.  Fourth universal definition of myocardial infarction (2018). , 2018, European heart journal.

[10]  K. Rentsch,et al.  Rhabdomyolysis: A Noncardiac Source of Increased Circulating Concentrations of Cardiac Troponin T? , 2018, Journal of the American College of Cardiology.

[11]  Kristian Thygesen,et al.  Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.

[12]  A. Jaffe,et al.  Comparison of high‐sensitivity cardiac troponin I and T for the prediction of cardiac complications after non‐cardiac surgery , 2018, American heart journal.

[13]  Ò. Miró,et al.  Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. , 2018, Clinical chemistry.

[14]  Mario Plebani,et al.  What to do when you question cardiac troponin values , 2018, European heart journal. Acute cardiovascular care.

[15]  A. Jaffe,et al.  How is cardiac troponin released from injured myocardium? , 2018, European heart journal. Acute cardiovascular care.

[16]  G. Guyatt,et al.  Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial , 2018, The Lancet.

[17]  Johannes Schmid,et al.  Elevated Cardiac Troponin T in Patients With Skeletal Myopathies. , 2018, Journal of the American College of Cardiology.

[18]  M. Seeberger,et al.  Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization , 2017, Circulation.

[19]  Pavel S. Roshanov,et al.  Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery , 2017, JAMA.

[20]  L. Rohde,et al.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology , 2017, Arquivos Brasileiros de Cardiologia.

[21]  D. Sessler,et al.  Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. , 2017, The Canadian journal of cardiology.

[22]  C. Mueller,et al.  Diurnal Rhythm of Cardiac Troponin: Consequences for the Diagnosis of Acute Myocardial Infarction. , 2016, Clinical chemistry.

[23]  H. Nathoe,et al.  One-Year Mortality, Causes of Death, and Cardiac Interventions in Patients with Postoperative Myocardial Injury , 2016, Anesthesia and analgesia.

[24]  P. Dagnelie,et al.  Direct comparison of clinical decision limits for cardiac troponin T and I , 2016, Heart.

[25]  K. Rentsch,et al.  Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin , 2015, Circulation.

[26]  Tej D. Azad,et al.  Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes , 2015, The Lancet.

[27]  B. Gorenek,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European journal of anaesthesiology.

[28]  J. Knuuti,et al.  New ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. , 2014, European heart journal.

[29]  Susanna Price,et al.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). , 2014, European heart journal.

[30]  A. Großhennig,et al.  Perioperative Levels and Changes of High-Sensitivity Troponin T Are Associated With Cardiovascular Events in Vascular Surgery Patients* , 2014, Critical care medicine.

[31]  Pavel S. Roshanov,et al.  Myocardial Injury after Noncardiac Surgery: A Large, International, Prospective Cohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes , 2014, Anesthesiology.

[32]  K. Rentsch,et al.  Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. , 2013, European heart journal.

[33]  A. Jaffe,et al.  High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. , 2013, American heart journal.

[34]  M. Seeberger,et al.  Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. , 2013, European heart journal.

[35]  F. Artunc,et al.  Sensitive Troponins – Which Suits Better for Hemodialysis Patients? Associated Factors and Prediction of Mortality , 2012, PloS one.

[36]  Paolo Pelosi,et al.  Mortality after surgery in Europe: a 7 day cohort study , 2012, The Lancet.

[37]  P. Lemos,et al.  Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous. , 2012, Atherosclerosis.

[38]  G. Guyatt,et al.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. , 2012, JAMA.

[39]  J. Tate,et al.  Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population , 2012, Clinical chemistry and laboratory medicine.

[40]  B. Biccard,et al.  Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta‐analysis , 2011, Anaesthesia.

[41]  B. Caramelli,et al.  Non-Cardiac Surgery in Developing Countries: Epidemiological Aspects and Economical Opportunities – The Case of Brazil , 2010, PloS one.

[42]  E F Cook,et al.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. , 1999, Circulation.

[43]  C. Herzog,et al.  Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. , 1997, Clinical chemistry.